Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C26 - Case Studies: Challenging Acute Ischemic Stroke Cases

Saturday 04/25/20
01:30 PM - 03:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Sarah Song, MD, MPH, FÂ鶹´«Ã½Ó³»­
Cerebrovascular Disease and Interventional Neurology
Participants will review challenging acute stroke cases with faculty experts and will learn how to promptly recognize IVtPA eligible cases that require special considerations, be aware of potential rare complications, and be comfortable in delivering IVtPA to acute stroke patients under special circumstances.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation
Event Timeline
01:00 PM - 01:05 PM Introduction Welcome
Sarah Song, MD, MPH, FÂ鶹´«Ã½Ó³»­
01:05 PM - 01:35 PM Speaker Tough TPA Case Decisions
Sarah Song, MD, MPH, FÂ鶹´«Ã½Ó³»­
01:35 PM - 02:10 PM Speaker Difficult Acute Stroke TPA Cases
Alejandro Vargas, MD, MS, FÂ鶹´«Ã½Ó³»­
02:10 PM - 02:45 PM Speaker Unusual TPA Cases
Laurel J. Cherian, MD, FÂ鶹´«Ã½Ó³»­
02:45 PM - 03:00 PM Q&A Questions and Answers
Faculty Disclosures
Sarah Song, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­.
Alejandro Vargas, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Laurel J. Cherian, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cherian has received research support from NIH.